Team:HokkaidoU Japan/Project/GSK

From 2011.igem.org

(Difference between revisions)
m
Line 27: Line 27:
==GSK tag==
==GSK tag==
 +
{|class="protein" style="text-align:center;"
{|class="protein" style="text-align:center;"
Line 37: Line 38:
|-
|-
|colspan="4" style="text-align:left;"|Discription
|colspan="4" style="text-align:left;"|Discription
-
|}
 
-
 
-
{|class="protein" style="text-align:center;"
 
|-
|-
!rowspan="2"|mnt repressor  
!rowspan="2"|mnt repressor  

Revision as of 09:12, 2 October 2011

Contents

GSK tag

Name Registry 2011 distribution length (bp) total molecular weight (kDa)
Discription
mnt repressor [http://partsregistry.org/Part:BBa_C0072 BBa_C0072] 1-12L 288 42.1
Discription
Gal4 DNA binding domain [http://partsregistry.org/Part:BBa_K105007 BBa_K105007] 3-9I 438 47.6
Discription
RFP [http://partsregistry.org/Part:BBa_J06504 BBa_J06504] 1-13F 714 57.7
Discription
GFP [http://partsregistry.org/Part:BBa_E0040 BBa_E0040] 1-14K 720 57.9
Discription
Cre DNA recombinase [http://partsregistry.org/Part:BBa_J61047 BBa_J61047] 1-5D 1037 69.6
Discription
CCR5 [http://partsregistry.org/Part:BBa_I712002 BBa_I712002] 2-3D 1059 70.4
Discription
LacI [http://partsregistry.org/Part:BBa_I732100 BBa_I732100] 2-10E 1086 71.4
Discription
Luciferase [http://partsregistry.org/Part:BBa_I712019 BBa_I712019] 1-10H 1653 92.1
Discription


Retrieved from "http://2011.igem.org/Team:HokkaidoU_Japan/Project/GSK"